Australian hearing health company, Nuheara (ASX:NUH) and Oto, the UK-based digital health company for tinnitus support, have announced “the world’s first collaboration to provide digital-led, tech-enabled support for people affected by tinnitus.”
The collaboration brings together Nuheara’s award-winning IQbuds² MAX hearing buds, which help “enable users to personalize and augment their hearing using smartphones and tablets,” with Oto’s mobile app that compiles and consolidates the latest therapy techniques to help “maximize quality of life for people with tinnitus.”
Tinnitus is reportedly more common than hearing loss. A new study published by The Lancet in January 2022, shows that almost 15% of people in Europe have tinnitus, which is estimated to be close to 65 million. The World Health Organization (WHO) reports as many as 42.7% of the global population experience tinnitus, a condition that can have a significant impact on mental health and quality of life.
Tinnitus is not well understood and according to the American Tinnitus Association (ATA) there are more than 200 different health conditions associated with its development.The UK’s National Institute for Health and Care Excellence guidance recommends digital cognitive behavioral therapy as first line therapy for tinnitus-related distress.
According to Justin Miller, CEO and co-founder Nuheara: “Since we launched IQbuds in 2016 we have found that for some people with tinnitus, our technology has been beneficial. Now with the Oto Tinnitus App collaboration, Nuheara’s customers will be able enjoy science-backed digital tinnitus support when they purchase the IQbuds² MAX/Oto bundle. Given more people experience tinnitus than hearing loss, this exciting collaboration means Nuheara can touch more people with an innovative hearing health solution.”
Commenting on the new announcements, former military and NHS doctor and Oto co-founder Dr Edmund Farrar said: “Our joint initiative with Nuheara, a pioneer and global leader in state-of-the-art hearable technology, is an important step for Oto and for the tinnitus community. Together we’ll be able to reach more people and help them to live their best life, uninterrupted by tinnitus thanks to best-in-class technology and Oto’s digital support platform.”
Nuheara will be selling IQbuds² MAX along with a 12-month Oto subscription to its customers in a bundle on the Nuheara ecommerce store.
- Biwas R, Lugo A, Akeroyd MA, Schlee W, Gallus S, Hall DA. Tinnitus prevalence in Europe: a multi-country cross-sectional population study. The Lancet. 2022;12:100250.
- World Health Organization (WHO). World Report on Hearing. https://www.who.int/publications/i/item/world-report-on-hearing. Published March 3, 2021.
- American Tinnitus Association (ATA) website. Tinnitus causes. https://www.ata.org/understanding-facts/causes.
Source: Nuheara, Oto